Pharmaceutical giant Eli Lilly said it will now move “with urgency” toward getting regulatory approval for orforglipron.
www.marketwatch.com
#Lilly #obesitypill #trial #results #find #warmer #reception #Wall #Street #time
Lilly obesity-pill trial results find a warmer reception on Wall Street this time around
